Cannabis Strategic Ventures (NUGS)

[Occasian]

Good question. Related companies (meaning directorship at these companies ancillary to this one) have been diluted, then undergone 15:1 reverse split $0.07 to $1.00, and another recently announced potential 300:1 max potential RS which would take them from $0.01 to $3.00.

This becomes a viable OTC vehicle to hitting the special case share price of 2 or 3 USD at closing for NASDAQ listing. I noticed this was a trend in OTC companies - raise a ton of capital, RS to get to uplisting price, uplist. Since they .have majority share voting rights, they can easily do this. Doesnt destroy shareholder value as the value of the stocks remain the same, just changes the perceived value because one owns less volume of shares. (Although there will be plenty of bitching if a RS occurs!)

The fundamental cashflow operations of NUGS makes me okay wIth a RS if necessary, although we would need policy changes to properly uplist to NASDAQ I believe. However with the ss changes and preferred C shares, that amount of shares still bothers me greatly. Can't put an exact reason why yet but time will tell - mainly the language stated their "value if converted to common shares" ... and the value was two to three orders of magnitude greater than anyone owns today.